Denali Therapeutics Inc.
METHODS FOR TREATING DYSREGULATED LIPID METABOLISM

Last updated:

Abstract:

Certain embodiments described herein provide a method for treating dysregulated lipid metabolism and/or inflammation in a mammal in need thereof, comprising administering to the mammal an effective amount of an agonist anti-triggering receptor expressed on myeloid cells 2 (TREM2) antibody.

Status:
Application
Type:

Utility

Filling date:

26 Nov 2019

Issue date:

27 Jan 2022